m
Recent Posts
Connect with:
Monday / December 2.
HomeminewsAvenova for DED to be Distributed by Designs for Vision

Avenova for DED to be Distributed by Designs for Vision

Paragon Care Group will distribute Avenova – a lid and lash spray for dry eye disease – directly to consumers under its Designs For Vision brand beginning in early 2021. The Australian company announced that it has signed an agreement for distribution of Avenova with NovaBay Pharmaceuticals.

“Avenova fits extremely well with our portfolio of eye care products,” said Nikolas Apostolou, General Manager of Designs for Vision. “It is the only commercially available pure hypochlorous acid lid and lash spray proven to be effective in eliminating the underlying cause of bacterial dry eye, yet Avenova is soothing, safe and effective for long-term use. We believe these qualities make Avenova the best product to treat the chronic bacterial infections that affect approximately 85% of all dry eye sufferers. We are thrilled to make this product available to Australians with dry eye disease.”

It is the only commercially available pure hypochlorous acid lid and lash spray proven to be effective in eliminating the underlying cause of bacterial dry eye

“We are delighted to expand the geographic reach of Avenova with this agreement covering Australia,” Justin Hall, NovaBay CEO, said in a company news release. “In Designs for Vision we have secured an ideal partner with a reputation for sourcing the highest quality products and an established market presence from more than 40 years of serving the ophthalmology and optometry sectors in Australia.”

Avenova is approved by Australia’s Therapeutic Goods Administration.

DECLARATION

DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.